Marimed (MRMD) Other financing activities (2013 - 2023)

Marimed (MRMD) reported Other financing activities of $1.5 million for Q4 2023, up 298.19% quarter-over-quarter from $387000.0 in Q1 2021.

Marimed (MRMD) Other financing activities (2013 - 2023) Analysis & Trends

Marimed (MRMD) has 6 years of Other financing activities data on file, last reported at $1.5 million in Q4 2023.

Other financing activities for Q4 2023 came in at $1.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $1.5 million (changed 0.0% YoY), and the FY2025 annual result was $9000.0, changed N/A from the prior year.
Other financing activities grew to $1.5 million in Q4 2023 per MRMD's latest filing, from $387000.0 in the prior quarter.
Over five years, Other financing activities peaked at $1.5 million in Q4 2023 and troughed at $387000.0 in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn
10	Marimed	-	-	15.28 Mn

Download Data